With the analysis among 1,424 patents, we discovered top 430 key players by total patent application. Amgen, Inc., Jenrin Discovery LLC, Arrowhead Pharmaceuticals, Inc. are dominant in this area. They take 9.41% of the total patent filing.
California, United States
Patent: 52
Pennsylvania, United States
Patent: 44
Arrowhead Pharmaceuticals, Inc.
California, United States
Patent: 38
Intercept Pharmaceuticals, Inc.
New York, United States
Patent: 26
Basel-Stadt, Switzerland
Patent: 25
Senju Pharmaceutical Beijing Co. Ltd.
Beijing Shi, China
Patent: 24
Aligos Therapeutics, Inc.
California, United States
Patent: 18
Nordrhein-Westfalen, Germany
Patent: 17
Espervita Therapeutics, Inc.
Michigan, United States
Patent: 17
California, United States
Patent: 16
With the analysis among 105 patents, we discovered top 25 start-ups by total patent application. Institut National de la Santé et de la Recherche Médicale, Espervita Therapeutics, Inc., I2o Therapeutics, Inc. are active in this area.
Institut National de la Santé et de la Recherche Médicale
Espervita Therapeutics, Inc.
Michigan, United States
Patent: 17
Massachusetts, United States
Patent: 8
Ashvattha Therapeutics Inc
California, United States
Patent: 5
Massachusetts, United States
Patent: 5
Massachusetts, United States
Patent: 4
Utrecht, Netherlands
Patent: 4
Kanagawa-ken, Japan
Patent: 3
With the analysis among related 1,111 patents applied in the last 5 years. We discover 407 most active companies in this area. The fast-growing Amgen, Inc., Arrowhead Pharmaceuticals, Inc., University of Connecticut take 10.26% of patent filing during this period.
California, United States
Patent: 52
Arrowhead Pharmaceuticals, Inc.
California, United States
Patent: 38
University of Connecticut
Connecticut, United States
Patent: 24
Aligos Therapeutics, Inc.
California, United States
Patent: 18
Espervita Therapeutics, Inc.
Michigan, United States
Patent: 17
Nordrhein-Westfalen, Germany
Patent: 17
Institut National de la Santé et de la Recherche Médicale
New York, United States
Patent: 13
Intercept Pharmaceuticals, Inc.
New York, United States
Patent: 13
Galmed Research & Development Ltd.
With the analysis among related 1,111 patents in last 5 years, we discover 333 new entrants. Amgen, Inc., Arrowhead Pharmaceuticals, Inc., University of Connecticut are the most active new entrants in this area.
California, United States
Patent: 52
Arrowhead Pharmaceuticals, Inc.
California, United States
Patent: 38
University of Connecticut
Connecticut, United States
Patent: 24
Aligos Therapeutics, Inc.
California, United States
Patent: 18
Espervita Therapeutics, Inc.
Michigan, United States
Patent: 17
Nordrhein-Westfalen, Germany
Patent: 17
New York, United States
Patent: 13
Galmed Research & Development Ltd.
Viking Therapeutics, Inc.
California, United States
Patent: 10
Joslin Diabetes Center, Inc.
Massachusetts, United States
Patent: 9
With the analysis among 448 patents, we discovered top 113 universities and scientific research institutions by total patent application. University of Connecticut, The Johns Hopkins University, Regents of the University of Colorado are dominant in this area. They take 17.41% of the total patent filing.
University of Connecticut
Connecticut, United States
Patent: 24
The Johns Hopkins University
Regents of the University of Colorado
Colorado, United States
Patent: 21
China Pharmaceutical University
Jiangsu Sheng, China
Patent: 11
Icahn School of Medicine at Mount Sinai
New York, United States
Patent: 6
Connecticut, United States
Patent: 5
The University of Southampton
SOUTHAMPTON, United Kingdom
Patent: 4
The University of North Carolina at Chapel Hill
North Carolina, United States
Patent: 4
Ruprecht-Karls-Universität Heidelberg
Baden-Württemberg, Germany
Patent: 4